Your browser doesn't support javascript.
loading
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
van Vollenhoven, Ronald F; Kalunian, Kenneth C; Dörner, Thomas; Hahn, Bevra H; Tanaka, Yoshiya; Gordon, Robert M; Shu, Cathye; Fei, Kaiyin; Gao, Sheng; Seridi, Loqmane; Gallagher, Patrick; Lo, Kim Hung; Berry, Pamela; Zuraw, Qing C.
Afiliação
  • van Vollenhoven RF; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands r.vanvollenhoven@amsterdamumc.nl.
  • Kalunian KC; Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, California, USA.
  • Dörner T; Department of Med./Rheumatology and Clinical Immunology, Charite Univ. Hospital, Berlin, Germany.
  • Hahn BH; Rheumatology, UCLA School of Medicine, Los Angeles, California, USA.
  • Tanaka Y; First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Gordon RM; Statistics and Decision Sciences, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Shu C; Clinical Development Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Fei K; Clinical Development Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Gao S; Translational Sciences and Medicine, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Seridi L; Translational Sciences and Medicine, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Gallagher P; Portfolio Delivery Operations, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Lo KH; Statistics and Decision Sciences, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Berry P; Immunology Strategic Market Access, Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, Pennsylvania, USA.
  • Zuraw QC; Clinical Development Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
Ann Rheum Dis ; 2022 Jul 07.
Article em En | MEDLINE | ID: mdl-35798534
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda